Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their voluntary written agreement to participate
- Native Chinese speakers
- Adults aged 18 to 60 years old, of any gender
- People with a body mass index (a height-to-weight measurement) between 18 and 30
- People whose general health has been assessed as low-to-moderate risk for surgery, based on two standard medical rating scales (confirm with trial site)
- People scheduled for a non-emergency keyhole (laparoscopic) surgery to remove colorectal cancer
- People whose surgery will use general anaesthesia with a breathing tube
- People who have experienced sleep problems or anxiety between being admitted to hospital and their surgery date, based on standard questionnaire scores (confirm with trial site)
Who may not be able to join:
- People for whom the medication Midazolam Oral Solution is medically unsuitable, based on the official prescribing information
- People who show a high risk of obstructive sleep apnoea, based on a standard screening tool score
- People where a screening test suggests possible dementia, with the score threshold depending on years of education (confirm with trial site)
- People who have had severe depression symptoms in the past two weeks, based on a standard questionnaire score
- People with a recorded history of neurological or psychiatric conditions
- People with a recorded history of chronic obstructive pulmonary disease (a long-term lung condition)
- People with a recorded history of heart failure
- People who currently have any type of bowel obstruction
- People with liver or kidney problems that affect normal organ function
- People who have taken opioid pain medicines or medications that affect the brain and nervous system within the past week
- People who have taken certain medications that interact with how the body processes Midazolam (known as CYP3A4 inhibitors or inducers) within the past week (confirm with trial site)
- People who have consumed any alcoholic drinks in the 24 hours before participation
- People with a history of substance misuse, including alcohol, drugs, or other addictive substances
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: sanqing Jin, MD, The Sixth Affiliated Hospital, Sun Yat-sen University
Phone: 0086-13719366863
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of moderate to severe pain on the first postoperative day
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.